TKI treatment for chronic myeloid leukaemia
14 Jul 2011
TKI treatment for chronic myeloid leukaemia
Communicating end of life options
Advances in the treatment of multiple myeloma
Development of lenvatinib for thyroid cancer
Health care issues in low and middle income countries.
The changing landscape of melanoma therapies: indications of better patient outcome
Role of vemurafenib in melanoma treatment
Research from the Sarah Cannon Research Institute
Clinical research at Sarah Cannon UK
2011 Gianni Bonadonna Breast Cancer Award and ASCO breast highlights
Treatment options for ovarian cancer
Standard of care for ovarian cancer